Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40
Sex
Women only
Ages
Ages 50 Years to 65 Years
Primary completion
2026-02-01
Last update
2026-03-13

What this trial studies

This study was conducted to examine the effects of exercise programs on the physical and psychosocial health of postmenopausal women. The postmenopausal period is characterized by an increased risk of problems such as decreased muscle strength, balance problems, fatigue, stress, and reduced quality of life due to hormonal changes. Therefore, appropriate exercise approaches are crucial during this period. The study evaluated the effects of regular and planned exercise programs on the physical functions and overall well-being of postmenopausal women.

Conditions in scope

  • Postmenopausal Period

Interventions

  • High-intensity functional exercise (Behavioral) — Participants in the exercise group followed a high-intensity functional exercise program designed to improve physical function, menopausal symptoms, and dual-task performance during the postmenopausal period.
  • moderate to low intensity exercise (Behavioral) — Control group participants performed moderate or low-intensity exercise.

Who can join

Women only · Ages 50 Years to 65 Years

Inclusion criteria

  • The participant must have had at least 12 months pass since their last menstrual period.
  • The participant must be between 50-65 years of age.
  • The participant must be able to walk independently.
  • The participant must have sufficient cognitive function.

Exclusion criteria

  • Neurological disorders
  • Active vestibular disorder
  • Lower extremity surgery or serious orthopedic injury
  • Severe arthritis and pain affecting walking
  • Use of sedative psychoactive drugs
  • Cognitive impairment

Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.

Where it’s happening

CityState / RegionFacilitySite status
Istanbul Üsküdar Üniversitesi Unknown

Status & timeline

  • Overall status: Completed
  • Study type: Interventional
  • Phase: N/A
  • Start date: 2025-11-29
  • Primary completion: 2026-02-01
  • Last update posted: 2026-03-13
  • First posted: 2026-03-13

Lead sponsor: Uskudar University (Other)

For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.

Outcome measures

Primary outcomes

  • short physical performance battery (8 weeks)
    Short Physical Performance Battery (SPPB) is a brief and standardized test battery used to assess lower-extremity physical performance, particularly in older adults. The test evaluates three main functional components: balance, gait speed, and chair-stand performance. Each subtest is scored between 0 and 4 points, resulting in a total score ranging from 0 to 12. Higher scores indicate better physical performance.…

If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.

Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT07471620 before contacting a site.

ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.